Line H. Dohn

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial.

ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 03, 2025

Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma.

Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma.

Journal: Scientific reports

Published: August 05, 2024

DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer.

DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer.

Journal: Scandinavian journal of urology

Published: October 19, 2023

The iBLAD app protocol - a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care.

The iBLAD app protocol - a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 30, 2023

The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial.

The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial.

Journal: Journal of patient-reported outcomes

Published: November 01, 2022

Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen.

Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: May 14, 2021

Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark.

Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: March 28, 2021

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder.

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder.

Journal: Cancers

Published: March 16, 2021

Status of Metastatic Bladder Cancer Treatment Illustrated by a Case.

Status of Metastatic Bladder Cancer Treatment Illustrated by a Case.

Journal: Seminars in oncology nursing

Published: January 10, 2021

Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.

Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.

Journal: Health and quality of life outcomes

Published: November 19, 2019

An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case.

An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case.

Journal: Scandinavian journal of urology

Published: January 03, 2018

Erratum: Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis.

Erratum: Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis.

Journal: Oncology letters

Published: June 08, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026